Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.
Looking for a particular Organogenesis employee's phone or email?
The Organogenesis annual revenue was $448.4 million in 2026.
Patrick Bilbo is the COO of Organogenesis.
710 people are employed at Organogenesis.
Organogenesis is based in Canton, Massachusetts.
The NAICS codes for Organogenesis are [325, 32].
The SIC codes for Organogenesis are [38, 384].